Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CF-IDEA trial of early insulin detemir in cystic fibrosis insulin deficiency
ACTRN12611000068965Phase 3Completed
- Sponsor
- Sydney Children's Hospital
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Phase 3, open-label trial of insulin detemir in cystic fibrosis (CF) (2 arms), sponsored by Sydney Children's Hospital. Primary endpoint: Prevention of decline in weight and lung function. Started Jan 2011; status: completed.
02
Drugs
insulin detemir
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on ACTRN12611000068965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000068965.